Even before the FDA's recent approval of Dato-DXd in breast cancer, analysts predicted sales of the antibody-drug conjugate ...

DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.

as confirmed by Marvel's vice president of production and development, Jonathan Schwartz: "It's present-day MCU, is what we're calling it. So, it exists along the timeline that the shows come out in.